FDA Warning Letter — Park Avenue Compounding
The FDA took a Warning Letter action against Park Avenue Compounding on Oct 19, 2015 (Saint Louis, MO). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Park Avenue Compounding
- Date
- Oct 19, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Saint Louis, MO (United States)